Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Khadirnaikar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2020
RNA-Sequencing Analysis Pipeline for Prognostic Marker Identification in CancerSudhanshu Shukla, Seema Khadirnaikar
The American Journal of Pathology|August 6, 2021
Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug SensitivitySeema Khadirnaikar, Annesha Chatterjee, Sudhanshu Shukla
Cancer Biomarkers : Section a of Disease Markers|September 6, 2021
Development and validation of stemness associated LncRNA based prognostic model for lung adenocarcinoma patientsAnnesha Chatterjee, Seema Khadirnaikar, Sudhanshu Shukla
Scientific Reports|March 22, 2023
Machine learning based combination of multi-omics data for subgroup identification in non-small cell lung cancerSeema Khadirnaikar, Sudhanshu Shukla, S R M Prasanna
Cancer Biomarkers : Section a of Disease Markers|July 19, 2021
Genetic and epigenetic landscape of leukocyte infiltration identifies an immune prognosticator in lung adenocarcinomaSeema Khadirnaikar, Annesha Chatterjee, Sudhanshu Kumar Shukla
Cancer Reports (Hoboken, N.J.)|August 15, 2020
Development and validation of an immune prognostic signature for ovarian carcinomaSeema Khadirnaikar, Pranjal Kumar, Sudhanshu Kumar Shukla
Journal of Cellular Physiology|February 12, 2019
A novel LncRNA-based prognostic score reveals TP53-dependent subtype of lung adenocarcinoma with poor survivalPranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla
Gene|January 15, 2019
PILAR1, a novel prognostic LncRNA, reveals the presence of a unique subtype of lung adenocarcinoma patients with KEAP1 mutationsPranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla
Frontiers in Oncology|August 28, 2020
A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor PrognosisSeema Khadirnaikar, Annesha Chatterjee, Pranjal Kumar, et al.
Biomarkers in Medicine|September 8, 2018
Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAsSeema Khadirnaikar, Sathiya Pandi Narayanan, Sudhanshu Kumar Shukla
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2020
RNA-Sequencing Analysis Pipeline for Prognostic Marker Identification in CancerSudhanshu Shukla, Seema Khadirnaikar
The American Journal of Pathology|August 6, 2021
Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug SensitivitySeema Khadirnaikar, Annesha Chatterjee, Sudhanshu Shukla
Cancer Biomarkers : Section a of Disease Markers|September 6, 2021
Development and validation of stemness associated LncRNA based prognostic model for lung adenocarcinoma patientsAnnesha Chatterjee, Seema Khadirnaikar, Sudhanshu Shukla
Scientific Reports|March 22, 2023
Machine learning based combination of multi-omics data for subgroup identification in non-small cell lung cancerSeema Khadirnaikar, Sudhanshu Shukla, S R M Prasanna
Cancer Biomarkers : Section a of Disease Markers|July 19, 2021
Genetic and epigenetic landscape of leukocyte infiltration identifies an immune prognosticator in lung adenocarcinomaSeema Khadirnaikar, Annesha Chatterjee, Sudhanshu Kumar Shukla
Cancer Reports (Hoboken, N.J.)|August 15, 2020
Development and validation of an immune prognostic signature for ovarian carcinomaSeema Khadirnaikar, Pranjal Kumar, Sudhanshu Kumar Shukla
Journal of Cellular Physiology|February 12, 2019
A novel LncRNA-based prognostic score reveals TP53-dependent subtype of lung adenocarcinoma with poor survivalPranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla
Gene|January 15, 2019
PILAR1, a novel prognostic LncRNA, reveals the presence of a unique subtype of lung adenocarcinoma patients with KEAP1 mutationsPranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla
Frontiers in Oncology|August 28, 2020
A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor PrognosisSeema Khadirnaikar, Annesha Chatterjee, Pranjal Kumar, et al.
Biomarkers in Medicine|September 8, 2018
Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAsSeema Khadirnaikar, Sathiya Pandi Narayanan, Sudhanshu Kumar Shukla
Pageof 2